|
|
Sigma Aldrich Corp (SIAL) |
|
|
|
| |
Sigma Aldrich's Customers Performance
SIAL
| |
|
SIAL's Source of Revenues |
Customers of Sigma Aldrich Corp saw their costs of revenue decrease by -8.03 % in Q3 compare to a year ago, sequentially costs of revenue were trimmed by -1.82 %, for the same period Sigma Aldrich Corp recorded revenue increase by 1.88 % year on year, sequentially revenue grew by 0.86 %.
• List of SIAL Customers
|
|
|
Customers of Sigma Aldrich Corp saw their costs of revenue decrease by -8.03 % in Q3 compare to a year ago, sequentially costs of revenue were trimmed by -1.82 %, for the same period Sigma Aldrich Corp recorded revenue increase by 1.88 % year on year, sequentially revenue grew by 0.86 %.
• List of SIAL Customers
|
Select the Relationship:
|
|
Select the Category:
|
|
|
Customers Net Income grew in Q3 by |
Customers Net margin grew to |
|
33.32 % |
18.96 % |
Sigma Aldrich's Comment on Sales, Marketing and Customers
The Company sold products and services to approximately 100,000 accounts representing
over 1.4 million individual customers, including pharmaceutical companies, universities,
commercial laboratories, industrial companies, biotechnology companies, non-profit
organizations, governmental institutions, diagnostic, chemical and electronics
companies and hospitals. Our Research and Applied business units, with an average
order size of approximately $500 dollars, accounted for 75 percent. Through
its SAFC Commercial business unit, the Company also makes its chemical products
available in larger-scale quantities for use in manufacturing.
Customers and potential customers, wherever located, are encouraged to contact
the Company by telephone or via its website (www.sigma-aldrich.com) to place
orders or obtain technical staff consultation. Information on the website does
not constitute a part of this Report. Shipments are made every scheduled work
day from all locations conducting distribution activities. The Company strives
to ship its products to customers on or near the same day an order is received
and carries inventory levels which it believes appropriate to maintain this
practice.
Sigma Aldrich's Comment on Sales, Marketing and Customers
The Company sold products and services to approximately 100,000 accounts representing
over 1.4 million individual customers, including pharmaceutical companies, universities,
commercial laboratories, industrial companies, biotechnology companies, non-profit
organizations, governmental institutions, diagnostic, chemical and electronics
companies and hospitals. Our Research and Applied business units, with an average
order size of approximately $500 dollars, accounted for 75 percent. Through
its SAFC Commercial business unit, the Company also makes its chemical products
available in larger-scale quantities for use in manufacturing.
Customers and potential customers, wherever located, are encouraged to contact
the Company by telephone or via its website (www.sigma-aldrich.com) to place
orders or obtain technical staff consultation. Information on the website does
not constitute a part of this Report. Shipments are made every scheduled work
day from all locations conducting distribution activities. The Company strives
to ship its products to customers on or near the same day an order is received
and carries inventory levels which it believes appropriate to maintain this
practice.
SIAL's vs. Customers, Data
(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)
| COMPANY NAME |
MARKET CAP |
REVENUES |
INCOME |
EMPLOYEES |
| Sigma Aldrich Corp |
0.00 |
4,724.00 |
491.00 |
9,300 |
| Abbvie Inc |
274,096.48 |
56,725.00 |
12,487.00 |
38,500 |
| Abbott Laboratories |
193,771.11 |
44,514.00 |
7,725.00 |
107,000 |
| Enact Holdings Inc |
3,502.40 |
4,921.24 |
1,223.62 |
19,200 |
| Allergan plc |
64,063.34 |
16,096.20 |
-2,478.80 |
10,500 |
| Alexion Pharmaceuticals Inc |
40,624.50 |
6,261.60 |
535.00 |
3,837 |
| Amgen Inc |
135,314.58 |
32,341.00 |
5,723.00 |
24,300 |
| Bard C R Inc |
28,674.68 |
5,307.70 |
689.80 |
13,900 |
| Becton Dickinson And Company |
71,741.39 |
20,032.00 |
1,920.00 |
72,000 |
| Biogen Inc |
30,323.68 |
10,819.50 |
1,541.50 |
9,100 |
| Bristol myers Squibb Company |
169,757.39 |
46,960.00 |
6,268.00 |
30,250 |
| Boston Scientific Corporation |
54,443.44 |
12,162.00 |
810.00 |
36,000 |
| Celgene Corp |
78,961.08 |
16,982.00 |
1,834.00 |
6,012 |
| Cephalon, Inc. |
0.00 |
0.00 |
0.00 |
0 |
| Quest Diagnostics Inc |
16,644.16 |
10,679.00 |
1,963.00 |
47,000 |
| Danaher Corporation |
186,837.28 |
30,283.00 |
6,456.00 |
60,000 |
| Davita Inc |
8,206.07 |
11,616.35 |
1,125.94 |
67,000 |
| Fresenius Medical Care Ag and Co Kgaa |
7,320.69 |
19,732.93 |
1,365.31 |
0 |
| Gilead Sciences Inc |
78,887.62 |
27,472.00 |
4,491.00 |
11,800 |
| Glaxosmithkline Plc |
219,503.18 |
34,114.00 |
5,096.00 |
0 |
| Hi crush Inc |
16.24 |
622.87 |
-554.27 |
0 |
| Heartland Media Acquisition Corp. |
138.98 |
0.00 |
-59.40 |
0 |
| Johnson and Johnson |
472,056.63 |
94,880.00 |
19,830.00 |
132,200 |
| Laboratory Corporation Of America Holdings |
22,567.07 |
15,859.00 |
2,101.50 |
65,000 |
| Eli Lilly And Company |
292,758.14 |
29,322.80 |
6,129.30 |
33,625 |
| MEDIMMUNE, INC. |
0.00 |
0.00 |
0.00 |
0 |
| Merck and Co Inc |
234,704.85 |
52,525.00 |
14,189.00 |
71,000 |
| Mylan N v |
8,208.13 |
16,861.30 |
266.40 |
25,000 |
| Patterson Companies Inc |
3,054.68 |
6,422.43 |
166.83 |
7,000 |
| Pfizer Inc |
293,514.05 |
92,367.00 |
25,009.00 |
88,300 |
| SCHERING-PLOUGH CORPORATION |
0.00 |
0.00 |
0.00 |
0 |
| Tenet Healthcare Corp |
6,337.53 |
19,449.00 |
1,534.00 |
108,000 |
| Thermo Fisher Scientific Inc |
212,055.75 |
41,123.00 |
7,611.00 |
75,000 |
| Varian Medical Systems Inc |
16,325.85 |
3,118.10 |
277.30 |
10,372 |
| Watson Pharmaceuticals Inc |
0.00 |
0.00 |
0.00 |
0 |
| Wyeth |
0.00 |
0.00 |
0.00 |
0 |
| Advanced Emissions Solutions Inc |
84.75 |
105.60 |
43.63 |
25 |
| Au Optronics Corp |
23,554.74 |
8,713.85 |
-686.66 |
60,083 |
| Avon Products Inc |
0.00 |
3,163.40 |
-226.60 |
33,200 |
| Axion Power International, Inc. |
0.30 |
-0.02 |
-12.08 |
16 |
| Newhydrogen Inc. |
25.47 |
0.00 |
10.19 |
1 |
| Cabot Corporation |
3,703.51 |
3,881.00 |
165.00 |
4,300 |
| Clarivate Plc |
11,224.25 |
1,610.24 |
-327.94 |
1,334 |
| Church and Dwight Co Inc |
22,830.85 |
5,248.40 |
811.20 |
4,800 |
| The Clorox Company |
17,311.19 |
7,108.00 |
467.00 |
8,800 |
| Css Industries Inc |
83.68 |
338.45 |
-26.91 |
1,200 |
| Ecolab Inc |
44,278.09 |
13,114.80 |
1,122.20 |
50,200 |
| Est e Lauder Companies Inc |
93,512.47 |
18,112.00 |
3,373.00 |
48,000 |
| Galenfeha, Inc. |
0.00 |
1.94 |
-0.32 |
1 |
| Corning Inc |
27,648.76 |
14,472.00 |
1,888.00 |
50,110 |
| Hawkins Inc. |
758.18 |
794.59 |
52.70 |
659 |
| Hexion Inc |
0.00 |
2,661.00 |
-80.00 |
4,300 |
| Lg Display Co Ltd |
2,171.51 |
27,786.58 |
1,240.20 |
53,891 |
| Procter and Gamble Co |
360,325.78 |
81,722.00 |
15,994.00 |
99,000 |
| The Sherwin williams Company |
59,336.94 |
20,287.30 |
1,825.60 |
61,111 |
| Sara Lee Corporation |
0.00 |
0.00 |
0.00 |
0 |
| Scott s Liquid Gold inc |
8.93 |
29.84 |
-11.26 |
67 |
| Usana Health Sciences Inc |
1,420.16 |
1,099.54 |
116.51 |
1,788 |
| Dentsply Sirona Inc |
7,992.69 |
4,251.00 |
421.00 |
15,200 |
| SUBTOTAL |
3,900,683.23 |
994,071.51 |
161,434.48 |
1,669,982 |
|
3.14 % 